Kiran Musunuru, MD, PhD, the Barry J. Gertz Professor for Translational Research at Penn Medicine, and Rebecca Ahrens-Nicklas, MD, PhD, Director of the Gene Therapy for Inherited Metabolic Disorders Frontier Program (GTIMD) at Children’s Hospital of Philadelphia and an Assistant Professor of Pediatrics at Penn Medicine, were recognized by TIME as pioneers in healthcare for successfully treating KJ Muldoon, an infant diagnosed with a rare genetic disorder, using a personalized CRISPR gene-editing therapy. Read more here.